MAILAH PANALIGAN-PATERNO: Open Payments
NPI 1548942915 · RINGGOLD, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 20 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $1,405 · 2025 $1,270
Food & beverage: $1,170Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $371 |
| Corcept Therapeutics | 2 | $153 |
| Janssen Biotech, Inc. | 1 | $150 |
| Insulet Corporation | 1 | $127 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| ABBVIE INC. | 2 | $35 |
| Abbott Laboratories | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 2 | $20 |
Products named: Veozah, Korlym, RYBREVANT, OMNIPOD, Auvelity, Rezzayo, VRAYLAR, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
